Literature DB >> 16596247

Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.

Adrian Cassidy1, Jonathan P Myles, Triantafillos Liloglou, Stephen W Duffy, John K Field.   

Abstract

Within the framework of the Liverpool Lung Project (LLP), population-based case-control and prospective cohort studies are in progress to identify molecular and epidemiological risk factors and define populations and individuals most at risk of developing lung cancer. This report describes a strategy for selection of a high-risk population and further provides support for the inclusion of occupational and genetic risk factors in future models. Data from the case-control study (256 incident cases and 314 population controls) were analysed to define a high-risk population. Detailed lifestyle and occupational information were collected during structured interviews. Models were constructed using conditional logistic regression and included terms for age, tobacco consumption and previous respiratory disease. Smoking duration was chosen as the most important predictor of lung cancer risk [>50 years (OR 15.65, 95% CI 6.10-40.15)]. However, such a model would preclude younger individuals. Several combinations of previous respiratory disease were also considered, of which a history of bronchitis, emphysema or pneumonia (BEP) was the most significant (OR 1.86, 95% CI 1.28-2.69). A high-risk subset (based on combinations of smoking duration and BEP) was identified, which have a 4.5-fold greater risk of developing lung cancer (OR 4.5, 95% CI 2.33-8.68). Future refinement of the risk model to include individuals occupationally exposed to asbestos and with the p21 genotypes is discussed. There is real potential for environmental and genetic factors to improve on risk prediction and targeting of susceptible individuals beyond the traditional models based only on smoking and age. The development of a molecular-epidemiological model will inform the development of effective surveillance, early detection and chemoprevention strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16596247

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Authors:  C Martin Tammemagi; Paul F Pinsky; Neil E Caporaso; Paul A Kvale; William G Hocking; Timothy R Church; Thomas L Riley; John Commins; Martin M Oken; Christine D Berg; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2011-05-23       Impact factor: 13.506

2.  Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial.

Authors:  Mathilde M Winkler Wille; Sarah J van Riel; Zaigham Saghir; Asger Dirksen; Jesper Holst Pedersen; Colin Jacobs; Laura Hohwü Thomsen; Ernst Th Scholten; Lene T Skovgaard; Bram van Ginneken
Journal:  Eur Radiol       Date:  2015-03-13       Impact factor: 5.315

3.  Family-based genetic risk prediction of multifactorial disease.

Authors:  Douglas M Ruderfer; Joshua Korn; Shaun M Purcell
Journal:  Genome Med       Date:  2010-01-15       Impact factor: 11.117

Review 4.  [Lung cancer screening - risk stratification : Who should undergo screening?].

Authors:  L Beer; H Prosch
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

5.  Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.

Authors:  Lisa D Gardner; Christopher A Loffredo PhD; Patricia Langenberg; Diane Marie St George; Janaki Deepak; Curtis C Harris; Sania Amr
Journal:  Ann Epidemiol       Date:  2018-05-07       Impact factor: 3.797

6.  Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells.

Authors:  Ellen Jorgensen; Andy Stinson; Lin Shan; Jin Yang; Diana Gietl; Anthony P Albino
Journal:  BMC Cancer       Date:  2008-08-11       Impact factor: 4.430

7.  Sleep duration and incidence of lung cancer in ageing men.

Authors:  Maria K Luojus; Soili M Lehto; Tommi Tolmunen; Arja T Erkkilä; Jussi Kauhanen
Journal:  BMC Public Health       Date:  2014-03-31       Impact factor: 3.295

8.  Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.

Authors:  Sarah J van Riel; Francesco Ciompi; Mathilde M Winkler Wille; Asger Dirksen; Stephen Lam; Ernst Th Scholten; Santiago E Rossi; Nicola Sverzellati; Matiullah Naqibullah; Rianne Wittenberg; Marieke C Hovinga-de Boer; Miranda Snoeren; Liesbeth Peters-Bax; Onno Mets; Monique Brink; Mathias Prokop; Cornelia Schaefer-Prokop; Bram van Ginneken
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

9.  Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.

Authors:  R P Young; R J Hopkins; G D Gamble
Journal:  Front Genet       Date:  2012-10-16       Impact factor: 4.599

10.  Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study.

Authors:  Hadrien Charvat; Shizuka Sasazuki; Taichi Shimazu; Sanjeev Budhathoki; Manami Inoue; Motoki Iwasaki; Norie Sawada; Taiki Yamaji; Shoichiro Tsugane
Journal:  Cancer Sci       Date:  2018-02-21       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.